Reverse Transcriptase Inhibitors (RTIs)

Reverse transcriptase inhibitors (RTIs) are a class of pharmaceutical drugs that exhibit the ability to block the action of reverse transcriptase enzymes Reverse transcriptase is an enzyme responsible for the conversion of single-stranded RNA into double-stranded DNA a crucial step in the replication of retroviruses like HIV By inhibiting this enzyme RTIs prevent the replication of the virus and the progression of the infection Our company offers a range of highly effective RTIs that have been designed to specifically target and inhibit reverse transcriptase offering hope for individuals living with retroviral infections

Get A Quote

Products Application Supporting Data Resources Related Products

Products

Catalog Number	Chemical Name	CAS #	Price
BC-0763	Abacavir hemisulfate	188062-50-2	Online Inquiry
BC-0768	Azidothymidine	30516-87-1	Online Inquiry
BC-0781	Didanosine	69655-05-6	Online Inquiry
BC-0784	Emtricitabine	143491-57-0	Online Inquiry
BC-0785	Etravirine	269055-15-4	Online Inquiry
BC-0796	MK-1439	1338225-97-0	Online Inquiry
BC-0809	Rilpivirine hydrochloride	700361-47-3	Online Inquiry
BC-0816	Stavudine	3056-17-5	Online Inquiry
BC-0819	Troviridine	149488-17-5	Online Inquiry
EI-2145	Tenofovir disoproxil fumarate	202138-50-9	Online Inquiry

Application

Reverse transcriptase inhibitors (RTIs) are essential tools in both research and medicine In the research field RTIs are commonly employed to study the reverse transcription process where RNA is converted into DNA By inhibiting reverse transcriptase scientists gain insights into the molecular mechanisms of viral replication and can develop strategies to combat viral infections

In medicine RTIs play a crucial role in the treatment of retroviral infections such as HIV By inhibiting the activity of reverse transcriptase these inhibitors prevent the conversion of viral RNA into DNA which is a critical step in the viral replication cycle This disruption helps to manage and control viral load ultimately improving the quality of life for patients and reducing the risk of progression to AIDS

Moreover RTIs have shown promise in other applications as well They are being explored for their potential in cancer treatment as some cancers rely on reverse transcription for their growth and survival By inhibiting this process RTIs have the potential to serve as targeted therapies against certain types of cancer

In summary reverse transcriptase inhibitors are indispensable tools in scientific research and play a crucial role in the treatment and management of retroviral infections like HIV Additionally their potential applications in cancer treatment highlight the versatility and wide-ranging impact of these inhibitors in the field of biology

Supporting Data

Resources

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.